StreetAlpha.app
Home › Stocks › CORT

Corcept Therapeutics Inc (CORT)

Healthcare
$70.07
▲ +1.23%
LAST CLOSE · NOV 17

Corcept Therapeutics sells Korlym for hypercortisolism and develops other drugs that act on the hormone cortisol. It last closed at $70.07 on Nov 17, up 1.23% on the day. CORT last reported earnings on Tue, Nov 3, 2026. Over the past 90 days StreetAlpha recorded 5 whale options trades in CORT, 20% of them bullish and 80% bearish. In the past 30 days there were 3 dark pool prints totaling $15.7M, the largest $9.1M.

AI Auto Pilots
Is CORT in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Revenue
$963.6M
+30.0% vs a year ago
Net income
$162.3M
+52.9% vs a year ago
EPS (diluted)
$1.33
+52.9% vs a year ago
Free cash flow
$194.6M
20.2% margin
Valuation
Market cap
$7.7B
109.4M shares
P/E
52.7
Price over 12 month EPS
Price to sales
8.0
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$98.7M
At Sep 30
Shareholder equity
$833.7M
Buybacks
$5.7M
Last 12 months
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: $366.0M$366.0MFY2021FY2022: $401.9M$401.9MFY2022FY2023: $482.4M$482.4MFY2023FY2024: $675.0M$675.0MFY2024FY2025: $761.4M$761.4MFY2025

From CORT's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 3). Last 12 months adds up the four latest quarters.

Last report
Nov 3
2026 · After the close (AMC)
Reported EPS
$1.01
vs $0.68 est. · beat
Year-ago EPS
—
Not on file
Options-implied move
±10.1%
Priced in before that report
Analyst consensus
1 Buy
1 firm · not enough for a consensus
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Ratings · 90 days
1 Buy
1firm
1 Buy0 Hold0 Sell
Only 1 firm rated CORT in the past 90 days, not enough for a consensus
Average 12-month target
$173.00
▲ 146.9% upside

Based on 1 analyst who set a price target on CORT in the past 90 days. The average target is $173.00, with a high of $173.00 and a low of $173.00, compared with the last close of $70.07.

Low $173.00Avg $173.00High $173.00
Blue marker: last close $70.07
Highest target$173.00
Average target$173.00
Lowest target$173.00
Latest rating changes
Piper SandlerTarget raised
Nov 4Buy$165 → $173
Piper SandlerReiterated
Jul 30Buy$165
Canaccord GenuityTarget raised
Jul 30Buy$150 → $161
HC Wainwright & Co.Target raised
Jul 30Buy$95 → $165
Canaccord GenuityTarget raised
Jul 29Buy$135 → $150
DateFirmActionRatingPrice target
Nov 4Piper SandlerTarget raisedBuy$165 → $173
Jul 30Piper SandlerReiteratedBuy$165
Jul 30Canaccord GenuityTarget raisedBuy$150 → $161
Jul 30HC Wainwright & Co.Target raisedBuy$95 → $165
Jul 29Canaccord GenuityTarget raisedBuy$135 → $150
Loading…

Technical Analysis

CORT · as of the Nov 17 close · updated after every close
Pullback inside a longer uptrend, oversold

The stock is 16% below its 20 day and 46% below its 50 day average. It is 10% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 25), oversold. The nearest support is the Pivot at $69.82, and the nearest resistance the Pivot R1 at $71.96.

Short trendBearish
Long trendBullish
MomentumWeak
StretchOversold
VolatilityHigh, 7.3%/day
Key levels
$126.3852 week high+80.4%
$103.29100 day average+47.4%
$101.9750 day average+45.5%
$85.40Swing high (Jun 17)+21.9%
$81.6320 day average+16.5%
$76.79200 day average+9.6%
$71.96Pivot R1+2.7%
$70.07Last close
$69.82Pivot−0.4%
$67.94Pivot S1−3.0%
$28.6652 week low−59.1%
Indicators
RSI (14)25.30Oversold below 30Oversold
MACD-9.76Below its signal lineBearish
Stochastic9.3Near the bottom of its rangeOversold
ADX (14)48.5Strong downtrend
Williams %R-88.3Oversold below −80, overbought above −20Oversold
CCI (20)-92.3Oversold below −100, overbought above 100Neutral
Rate of change−14.5%Change over 10 sessionsBearish
ATR (14)$5.12Typical daily range, 7.3% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for CORT

What happened before

See how CORT did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

Whale flow leans bearish1 bullish and 4 bearish whale options trades in the last 90 days. See Whale Flow
November seasonalityHow CORT usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Seasonality

How CORT has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2006.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Total alerts
5
Bullish
1
20%
Bearish
4
80%
Date span
Sep 29 – Nov 9
Loading…

See today’s whale options flow across the market →

Dark Pool

30D
Prints
3
Notional
$15.7M
Largest print
$9.1M
Loading…

CORT Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Neutral
Strongly bearishNeutralStrongly bullish
  • ▲288 buying vs 187 selling
  • ▼Held by funds -2.0 pts
  • ▲Funds holding +77
  • ▲Superinvestors: 2 added, 1 cut
  • ▼Put/call 0.14 to 1.57
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding501424+18.2%
In funds' top 10118+37.5%
Held by funds73.2%75.3%−2.0 pts
New / increased121 / 167126 / 146+5.9%
Reduced / sold out149 / 38108 / 56+14.0%
Put/call ratio1.570.14+1038.4%
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See CORT institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether CORT is in one of them and how their past CORT trades turned out.

CORT in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered CORT in an article yet. Here's the latest on the wider market.

CORT Congress Trades

All congress trades →
Trades, 12 months
4
Buys
2
50%
Sells
1
25%
People
1
Last filed Sep 22
Who traded CORT · since 2026
Latest 4 filings
$1K – $15KTraded Jul 29, 2026Filed Sep 22, 2026
$15K – $50KTraded Mar 30, 2026Filed May 14, 2026
$15K – $50KTraded Mar 4, 2026Filed May 14, 2026
$50K – $100KTraded Feb 26, 2026Filed May 14, 2026
PersonTypeAmountTradedFiledDelay
Donald J TrumpExecutive branchSell$1K – $15KJul 29, 2026Sep 22, 202655 d
Donald J TrumpExecutive branchOther$15K – $50KMar 30, 2026May 14, 202645 d
Donald J TrumpExecutive branchBuy$15K – $50KMar 4, 2026May 14, 202671 d
Donald J TrumpExecutive branchBuy$50K – $100KFeb 26, 2026May 14, 202677 d

Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.

About Corcept Therapeutics

Corcept Therapeutics is a pharmaceutical company based in Redwood City, California, that develops medicines acting on the hormone cortisol. Its main product is Korlym, along with a generic version of it, used to treat hypercortisolism, also called Cushing's syndrome. The company sells these products in the United States through sales representatives who call on physicians treating patients with the condition. It is also testing cortisol-related drug candidates for other conditions, including some cancers, ALS and a liver disease.

Headquarters
Redwood City, CA
Founded
1998